With two on-label agents now available, the panel turns to what actually drives the choice between them, noting how recently ...

Former NASCAR driver Darrell Waltrip recently announced a diagnosis of frontotemporal dementia (FTD). Waltrip, a 3-time ...

Newly announced Phase 4 THRIVE trial results showed most patients who previously had an inadequate response to a ...

The FDA was busy in September 2026, issuing a number of decisions on potential new therapies, including approvals, clearances ...

Neurology moves fast, and the assumptions that shape how we practice do not always keep up. Gray Areas is a NeurologyLive ...